First Blood test unveiled for cancer detection in dogs

Richmond, British Columbia -

Cancer detection in dogs may now be possible with a simple blood test.

BioCurex announced the availability of the OncoPet RECAF test, which has

detected 85 percent of a variety of cancers in dogs at the standard 95 percent

specificity level in premarket studies.

The test detects whether RECAF, a universal marker for malignant cell growth

in animals and people, is present in the blood. RECAF's expression is related

to rapid cell growth, which is characteristic of cancer and fetal development.

The same blood test is used in people.

The test will be available through OncoPet Diagnostics Inc., a subsidiary of

BioCurex. Depending on the location of your practice, you can send the samples

to the OncoPet testing facility directly or to a regional collection center.

OncoPet is in discussions with North American and Canadian distributors.

BioCurex hopes to have simular test for other companion animals - cats in

particular - in the second half of this year.

Referance - DVM Newsmagazine April 2010